Epidemiology and etiology of mantle cell lymphoma and other non-Hodgkin lymphoma subtypes

Rappaport, 1956, Follicular lymphoma. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases, Cancer, 9, 792, 10.1002/1097-0142(195607/08)9:4<792::AID-CNCR2820090429>3.0.CO;2-B Banks, 1992, Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data, Am J Surg Pathol, 16, 637, 10.1097/00000478-199207000-00001 Harris, 1994, A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group, Blood, 84, 1361, 10.1182/blood.V84.5.1361.1361 2001 Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516 1997, A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project, Blood, 89, 3909, 10.1182/blood.V89.11.3909 Zhou, 2008, Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004, Cancer, 113, 791, 10.1002/cncr.23608 Sant, 2010, Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project, Blood, 116, 3724, 10.1182/blood-2010-05-282632 Morton, 2006, Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001, Blood, 107, 265, 10.1182/blood-2005-06-2508 2008 Coleman, 1993 Roman, 2011, Epidemiology of lymphomas, Histopathology, 58, 4, 10.1111/j.1365-2559.2010.03696.x Marcos-Gragera, 2010, Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain, Ann Oncol, 21, iii90, 10.1093/annonc/mdq088 Sandin, 2006, Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was, Cancer Epidemiol Biomarkers Prev, 15, 1295, 10.1158/1055-9965.EPI-05-0958 Hartge, 1992, Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence, Cancer Res, 52, 5566s Boffetta, 2007, Consortia in cancer epidemiology: lessons from InterLymph, Cancer Epidemiol Biomarkers Prev, 16, 197, 10.1158/1055-9965.EPI-06-0786 Ekstrom-Smedby, 2006, Epidemiology and etiology of non-Hodgkin lymphoma – a review, Acta Oncol, 45, 258, 10.1080/02841860500531682 Clarke, 2006, Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study, Cancer Epidemiol Biomarkers Prev, 15, 630, 10.1158/1055-9965.EPI-05-0549 Grogg, 2007, HIV infection and lymphoma, J Clin Pathol, 60, 1365, 10.1136/jcp.2007.051953 Quinlan, 2011, Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States, Am J Hematol, 86, 206, 10.1002/ajh.21911 Royer, 1997, Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses, Blood, 90, 766, 10.1182/blood.V90.2.766 Theander, 2011, Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren's syndrome, Ann Rheum Dis, 70, 1363, 10.1136/ard.2010.144782 Wotherspoon, 1991, Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma, Lancet, 338, 1175, 10.1016/0140-6736(91)92035-Z Lin, 2010, Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma, Cancer Res, 70, 5740, 10.1158/0008-5472.CAN-09-4690 van Leeuwen, 2009, Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation, Blood, 114, 630, 10.1182/blood-2009-02-202507 van Leeuwen, 2009, Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy, AIDS, 23, 2183, 10.1097/QAD.0b013e328331d384 Epeldegui, 2010, HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma, Immunol Res, 48, 72, 10.1007/s12026-010-8168-8 Fernberg P, Edgren G, Adami J, Ingvar A, Bellocco R, Tufveson G, et al. Time trends in risk and risk determinants of non-Hodgkin lymphoma in solid organ transplant recipients. Am J Transplant; 2011 Aug 22 [Epub ahead of print]. Jarrett, 2006, Viruses and lymphoma/leukaemia, J Pathol, 208, 176, 10.1002/path.1905 Giordano, 2007, Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus, JAMA, 297, 2010, 10.1001/jama.297.18.2010 Engels, 2010, Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study, Lancet Oncol, 11, 827, 10.1016/S1470-2045(10)70167-4 de Sanjose, 2008, Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium, Clin Gastroenterol Hepatol, 6, 451, 10.1016/j.cgh.2008.02.011 Ferreri, 2009, Chlamydial infection: the link with ocular adnexal lymphomas, Nat Rev Clin Oncol, 6, 658, 10.1038/nrclinonc.2009.147 Peterson, 2004, Immunoproliferative small intestinal disease associated with Campylobacter jejuni, N Engl J Med, 350, 1685, 10.1056/NEJM200404153501619 Garbe, 1991, Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases, J Am Acad Dermatol, 24, 584, 10.1016/0190-9622(91)70088-J Munksgaard, 2004, Demonstration of B. burgdorferi-DNA in two cases of nodal lymphoma, Leuk Lymphoma, 45, 1721, 10.1080/10428190410001683723 Schöllkopf, 2008, Borrelia infection and risk of non-Hodgkin lymphoma, Blood, 111, 5524, 10.1182/blood-2007-08-109611 Aberer, 2011, Within European margins, Lancet, 377, 178, 10.1016/S0140-6736(10)62241-6 Thelander, 2008, Molecular genetic characterization reveals new subsets of mantle cell lymphoma, Leuk Lymphoma, 49, 1042, 10.1080/10428190801947559 Garcia-Munoz, 2009, Autoimmunity and lymphoma: is mantle cell lymphoma a mistake of the receptor editing mechanism?, Leuk Res, 33, 1437, 10.1016/j.leukres.2009.05.008 Schraders, 2009, Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity, Mod Pathol, 22, 416, 10.1038/modpathol.2008.199 Hadzidimitriou, 2011, Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases, Blood, 118, 2088, 10.1182/blood-2011-03-343434 Romaguera, 2003, Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma, Cancer, 97, 586, 10.1002/cncr.11096 Rule, 2011, Indolent mantle-cell lymphoma: immunoglobulin variable region heavy chain sequence analysis reveals evidence of disease 10 years prior to symptomatic clinical presentation, J Clin Oncol, 29, e437, 10.1200/JCO.2010.31.8006 Smedby, 2008, Autoimmune and inflammatory disorders and risk of malignant lymphomas – an update, J Intern Med, 264, 514, 10.1111/j.1365-2796.2008.02029.x Smedby, 2006, Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype, J Natl Cancer Inst, 98, 51, 10.1093/jnci/djj004 Ekstrom Smedby, 2008, Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium, Blood, 111, 4029, 10.1182/blood-2007-10-119974 Willett, 2008, Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium, Int J Cancer, 122, 2062, 10.1002/ijc.23344 Morton, 2005, Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis, Lancet Oncol, 6, 469, 10.1016/S1470-2045(05)70214-X Morton, 2005, Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph), Cancer Epidemiol Biomarkers Prev, 14, 925, 10.1158/1055-9965.EPI-04-0693 Kricker, 2008, Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium, Int J Cancer, 122, 144, 10.1002/ijc.23003 Vajdic, 2009, Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis, Cancer Res, 69, 6482, 10.1158/0008-5472.CAN-08-4372 Clapp, 2008, Environmental and occupational causes of cancer: new evidence 2005–2007, Rev Environ Health, 23, 1, 10.1515/REVEH.2008.23.1.1 Eriksson, 2008, Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis, Int J Cancer, 123, 1657, 10.1002/ijc.23589 Cocco, 2010, Occupational exposure to solvents and risk of lymphoma subtypes: results from the Epilymph case–control study, Occup Environ Med, 67, 341, 10.1136/oem.2009.046839 Kane, 2010, Occupational exposure to gasoline and the risk of non-Hodgkin lymphoma: a review and meta-analysis of the literature, Cancer Epidemiol, 34, 516, 10.1016/j.canep.2010.05.012 Wang, 2007, Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10211 cases and 11905 controls from the International Lymphoma Epidemiology Consortium (InterLymph), Blood, 109, 3479, 10.1182/blood-2006-06-031948 Chang, 2005, Family history of hematopoietic malignancy and risk of lymphoma, J Natl Cancer Inst, 97, 1466, 10.1093/jnci/dji293 Goldin, 2004, Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database, Blood, 104, 1850, 10.1182/blood-2004-01-0341 Chang, 2006, Reliability of self-reported family history of cancer in a large case–control study of lymphoma, J Natl Cancer Inst, 98, 61, 10.1093/jnci/djj005 Conde, 2010, Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32, Nat Genet, 42, 661, 10.1038/ng.626 Houlston, 2010, Low-penetrance susceptibility to hematological malignancy, Curr Opin Genet Dev, 20, 245, 10.1016/j.gde.2010.03.004 Rothman, 2006, Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium, Lancet Oncol, 7, 27, 10.1016/S1470-2045(05)70434-4 Fernberg, 2010, Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma, Cancer Causes Control, 21, 759, 10.1007/s10552-010-9504-y Skibola, 2010, Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium, Am J Epidemiol, 171, 267, 10.1093/aje/kwp383 Elahi, 2009, Tumor necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease, Biochim Biophys Acta, 1792, 163, 10.1016/j.bbadis.2009.01.007 Gibson, 2001, Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus, J Immunol, 166, 3915, 10.4049/jimmunol.166.6.3915 Balkwill, 2009, Tumour necrosis factor and cancer, Nat Rev Cancer, 9, 361, 10.1038/nrc2628 Slager, 2011, Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL, Blood, 117, 1911, 10.1182/blood-2010-09-308205 Crowther-Swanepoel, 2010, Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk, Nat Genet, 42, 132, 10.1038/ng.510 Smedby, 2011, GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma, PLoS Genet, 7, e1001378, 10.1371/journal.pgen.1001378